- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-34-0015216

Bulwark Laboratories Private Limited
About Bulwark Laboratories Private Limited
Data last updated:
Bulwark Laboratories Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85195TN1980PTC008090. Its GSTIN is 33AAFCB0363F1Z7 (Tamil Nadu).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rosh Thomas and Padmana Thomas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/279 Pillayar Koil Street Thoraipakkam, Chennai, Tamil Nadu, India – 600097.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.58 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹63.08 Lakh (net margin 39.9%) and EBITDA of ₹1.15 Cr (EBITDA margin 72.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹2.6 Cr and satisfied charges of ₹50 Lakh on record.
Bulwark Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-34-0015216). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Bulwark Laboratories
Contact details
Bulwark Laboratories Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2/279 Pillayar Koil Street Thoraipakkam, Chennai, Tamil Nadu, India – 600097
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bulwark Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bulwark Laboratories Private Limited
FY 2025 filings availableBulwark Laboratories Private Limited reported revenue of ₹1.58 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 12% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 72.8% | ||||
| Net Profit Margin | 39.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bulwark Laboratories Private Limited, buy the company report.
Board of directors of Bulwark Laboratories Private Limited
Bulwark Laboratories has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rosh Thomas | Director | 19 Sep 2005 | 21 Years 1 Months | Current |
| Padmana Thomas | Director | 21 Jan 1980 | 46 Years 9 Months | Current |
| Maya Rosh Thomas | Director | 16 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Bulwark Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Agriculture industry (Fertilizers, Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ocean Organics Private Limited | ₹1.59 Cr (FY 2024) | 30.0% | Punjab, India | |||
| Gendox Healthcare Private Limited | ₹1.59 Cr (FY 2025) | 20.0% | New Delhi, Delhi, India | |||
| Nemed Healthcare Private Limited | ₹1.59 Cr (FY 2025) | 34.0% | Guwahati, Assam, India | |||
| Fairdeal Formulations (India) Pvt Ltd | ₹1.59 Cr (FY 2025) | 72.0% | Indore, Madhya Pradesh, India | |||
| Vipram Agri Industries Private Limited | ₹1.58 Cr (FY 2020) | -28.0% | Sikandrabad, Uttar Pradesh, India | |||
| Bulwark Laboratories Private Limitedthis company | ₹1.58 Cr (FY 2025) | ₹63.08 Lakh | 39.9% | 12.0% | Chennai, Tamil Nadu, India | |
| Starlet Agri Sciences Private Limited | ₹1.58 Cr (FY 2016) | 147.0% | Hyderabad, Telangana, India | |||
| Livewort Labs Private Limited | ₹1.58 Cr (FY 2024) | 20.0% | Chandigarh, India | |||
| Roos Tempkool Limited | ₹1.58 Cr (FY 2025) | -22.0% | Kolkata, West Bengal, India | |||
| Suzrayn Pharma Private Limited | ₹1.58 Cr (FY 2022) | 33.0% | Chitradurga, Karnataka, India | |||
| Elcliff Formulations Private Limited | ₹1.58 Cr (FY 2025) | -31.0% | Yamuna Nagar, Haryana, India |
To see the full peer comparison of Bulwark Laboratories Private Limited, buy the company report.
Auditor
Bulwark Laboratories Private Limited is audited by RANGAN & KRISHNAN for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANGAN & KRISHNAN | FY 2021 | 003054S |
Shareholding
The shareholding of Bulwark Laboratories Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bulwark Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Mar 2021 | 100445435 | Others | ₹2.6 Cr | Open | |
| 16 Nov 2016 | 100063205 | Others | ₹50 Lakh | Satisfied |
To see the full charge records of Bulwark Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Bulwark Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bulwark Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bulwark Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCB0363F1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bulwark Laboratories Private Limited, buy the company report.
Recent activity
Bulwark Laboratories Private Limited has 5 board changes on record since 1980: 3 appointments and 2 cessations. The latest: Thomas Thomas ceased to be Director on 28 Jan 2022.
Frequently asked questions
Bulwark Laboratories is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 1980 (46+ years old) and is registered under CIN U85195TN1980PTC008090.
Bulwark Laboratories has 3 current directors:
- Rosh Thomas - Director
- Padmana Thomas - Director
- Maya Rosh Thomas - Director
The latest financial statements of Bulwark Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bulwark Laboratories is 33AAFCB0363F1Z7, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Bulwark Laboratories is U85195TN1980PTC008090. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bulwark Laboratories was incorporated on 21 January 1980, making it 46+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Bulwark Laboratories by revenue are Ocean Organics Private Limited, Gendox Healthcare Private Limited, Nemed Healthcare Private Limited, Fairdeal Formulations (India) Pvt Ltd, Vipram Agri Industries Private Limited and 5 more, all in the Agriculture industry (Fertilizers, Formulations).
Thomas Thomas ceased to be Director on 28 Jan 2022. Maya Rosh Thomas ceased to be Additional Director on 30 Sep 2016. Maya Rosh Thomas was appointed as Director on 16 Aug 2016. Bulwark Laboratories has 5 board changes on record in total.
Yes, Bulwark Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-34-0015216).
The registered office of Bulwark Laboratories is at 2279 Pillayar Koil Street Thoraipakkam, Chennai, Tamil Nadu, India – 600097.
Bulwark Laboratories operates in the pharma industry, in the drug formulation and development segment.

